Task: Answer the multiple-choice question.
Query: Which drug exhibits a 17.295\% hERG inhibition at a concentration of 1uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
a: Cc1c(C(=O)NC2=NCCS2)oc2ccccc12
b: CCCSc1nsc(NC(=O)C(c2ccccc2)c2ccccc2)n1
c: CCn1cc(Cl)c(C(=O)Nc2cccc(CN3CCOCC3)c2)n1
d: CC(C)(C)NC(=O)C1CCN(S(=O)(=O)c2cccc(C(F)(F)F)c2)CC1
e: CCC1(c2ccccc2)ON(c2c(Br)cccc2Br)C1=O
Answer: e. CCC1(c2ccccc2)ON(c2c(Br)cccc2Br)C1=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC1(c2ccccc2)ON(c2c(Br)cccc2Br)C1=O
CCC1(c2ccccc2)ON(c2c(Br)cccc2Br)C1=O
2-(2,6-dibromophenyl)-4-ethyl-4-phenyloxazetidin-3-one